WO1998027932A3 - Cerebellum and embryo specific protein - Google Patents

Cerebellum and embryo specific protein Download PDF

Info

Publication number
WO1998027932A3
WO1998027932A3 PCT/US1997/023518 US9723518W WO9827932A3 WO 1998027932 A3 WO1998027932 A3 WO 1998027932A3 US 9723518 W US9723518 W US 9723518W WO 9827932 A3 WO9827932 A3 WO 9827932A3
Authority
WO
WIPO (PCT)
Prior art keywords
cerebellum
cesp
embryo specific
specific protein
protein
Prior art date
Application number
PCT/US1997/023518
Other languages
French (fr)
Other versions
WO1998027932A2 (en
Inventor
Daniel R Soppet
Steven M Ruben
Original Assignee
Human Genome Sciences Inc
Daniel R Soppet
Steven M Ruben
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc, Daniel R Soppet, Steven M Ruben filed Critical Human Genome Sciences Inc
Priority to CA002275540A priority Critical patent/CA2275540A1/en
Priority to EP97952549A priority patent/EP0954575A2/en
Priority to JP52898298A priority patent/JP2001507227A/en
Priority to AU56134/98A priority patent/AU5613498A/en
Publication of WO1998027932A2 publication Critical patent/WO1998027932A2/en
Publication of WO1998027932A3 publication Critical patent/WO1998027932A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/515—Angiogenesic factors; Angiogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Abstract

The present invention relates to a novel cerebellum and embryo specific (CESP) protein which is a member of the myocardial factor superfamily. In particular, isolated nucleic acid molecules are provided encoding the human CESP protein. CESP polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same.
PCT/US1997/023518 1996-12-20 1997-12-18 Cerebellum and embryo specific protein WO1998027932A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002275540A CA2275540A1 (en) 1996-12-20 1997-12-18 Cerebellum and embryo specific protein
EP97952549A EP0954575A2 (en) 1996-12-20 1997-12-18 Cerebellum and embryo specific protein
JP52898298A JP2001507227A (en) 1996-12-20 1997-12-18 Cerebellar and embryo specific proteins
AU56134/98A AU5613498A (en) 1996-12-20 1997-12-18 Cerebellum and embryo specific protein

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3387096P 1996-12-20 1996-12-20
US60/033,870 1996-12-20

Publications (2)

Publication Number Publication Date
WO1998027932A2 WO1998027932A2 (en) 1998-07-02
WO1998027932A3 true WO1998027932A3 (en) 1999-01-28

Family

ID=21872929

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/023518 WO1998027932A2 (en) 1996-12-20 1997-12-18 Cerebellum and embryo specific protein

Country Status (6)

Country Link
US (1) US20030004327A1 (en)
EP (1) EP0954575A2 (en)
JP (1) JP2001507227A (en)
AU (1) AU5613498A (en)
CA (1) CA2275540A1 (en)
WO (1) WO1998027932A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7057017B2 (en) 1997-04-16 2006-06-06 Millennium Pharmaceuticals, Inc. Human dickkopf-related protein and nucleic acid molecules and uses therefor
DK0975755T3 (en) * 1997-04-16 2007-06-11 Millennium Pharm Inc CRSP protein (cysteine-rich secreted proteins), encoding nucleic acid molecules, and uses thereof
DE19747418C1 (en) 1997-10-27 1999-07-15 Deutsches Krebsforsch Inhibitor protein of the wnt signaling pathway
US7446181B2 (en) 1998-01-15 2008-11-04 Millennium Pharmaceuticals, Inc. Antibodies that bind human Dickkopf-1 proteins
US6344541B1 (en) * 1998-09-25 2002-02-05 Amgen Inc. DKR polypeptides
EP1161445A2 (en) * 1999-03-05 2001-12-12 Millennium Pharmaceuticals, Inc. Human dickkopf-related protein and nucleic acid molecules and uses therefor
EP1234877B1 (en) * 1999-11-19 2010-06-02 Kumon, Hiromi Cell proliferation inhibitory protein, polynucleotide, antisense polynucleotide to the polynucleotide, and cell proliferation inhibitors, cancer diagnostics, cancer remedies and compositions for gene therapy by using the same
AU3589101A (en) * 2000-02-24 2001-09-03 Oxford Glycosciences (Uk) Limited Dpi-6, a putative therapeutic target and biomarker in neuropsychiatric and neurological disorders
AU2005267722B2 (en) 2004-08-04 2009-10-08 Amgen Inc. Antibodies to Dkk-1

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992006194A1 (en) * 1990-09-27 1992-04-16 Consiglio Nazionale Delle Ricerche Nucleotide sequences coding for a human protein with angiogenesis regulative properties

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004527210A (en) * 2000-08-02 2004-09-09 ザ ジョンズ ホプキンス ユニバーシティー Evaluation method of endothelial cell expression pattern

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992006194A1 (en) * 1990-09-27 1992-04-16 Consiglio Nazionale Delle Ricerche Nucleotide sequences coding for a human protein with angiogenesis regulative properties

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HILLIER ET AL.: "The WashU-Merch EST Project", EMBL DATABASE EMEST9, 16 December 1995 (1995-12-16), EST HS266245;w99c06.s1 Homo sapiens cDNa clone 260362 3' Accession number H99266, XP002084753 *
HILLIER L ET AL.: "The washU-Merck EST Project", EMBL DATABASE EMEST8, 27 May 1996 (1996-05-27), EST HS126340;zc20c09.s1 Soares enescent fibroblasts NbHSF Homo sapiens cDNA clone 322864 3' Accession number W45126, XP002084754 *
MAZUR W ET AL: "Coronary Restenosis and Gene Therapy", TEXAS HEART INSTITUTE JOURNAL, vol. 21, no. 1, 1994, pages 104 - 111, XP000619173 *

Also Published As

Publication number Publication date
US20030004327A1 (en) 2003-01-02
WO1998027932A2 (en) 1998-07-02
AU5613498A (en) 1998-07-17
EP0954575A2 (en) 1999-11-10
CA2275540A1 (en) 1998-07-02
JP2001507227A (en) 2001-06-05

Similar Documents

Publication Publication Date Title
CA2285040A1 (en) Death domain containing receptor 5
WO1998031818A3 (en) Tace-like and matrilysin-like polypeptides
WO1998031800A3 (en) Human proteins
WO1998039446A3 (en) 70 human secreted proteins
WO1998039448A3 (en) 186 human secreted proteins
EP1009814A4 (en) Human receptor tyrosine kinase, kdr
AU6847896A (en) Human endokine alpha
EP1003767A4 (en) Human tumor necrosis factor receptor tr10
WO1998045712A3 (en) 20 human secreted proteins
EP1401477A4 (en) Chemokine beta-1 fusion proteins
EP1054958A4 (en) Human serine protease and serpin polypeptides
WO1995006735A3 (en) Nucleotide sequences for novel protein tyrosine phosphatases
WO2000017222A8 (en) 31 human secreted proteins
WO2000066156A8 (en) Death domain containing receptor 5
WO1998027932A3 (en) Cerebellum and embryo specific protein
WO2000052136A3 (en) Human glycosylation enzymes
WO2000067793A8 (en) Death domain containing receptor 4
WO2003008449A8 (en) Ntb-a, a surface molecule involved in natural killer cells activity
WO2000050620A3 (en) Human endokine alpha and methods of use
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
WO1997002730A3 (en) Enamel matrix related polypeptide
WO2002090500A3 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
WO1998029438A3 (en) Cortistatin polypeptides
AU7610396A (en) Connective tissue growth factor-3
WO2002046408A3 (en) Human proteins, polynucleotides encoding them and methods of using the same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref document number: 2275540

Country of ref document: CA

Ref country code: JP

Ref document number: 1998 528982

Kind code of ref document: A

Format of ref document f/p: F

Ref country code: CA

Ref document number: 2275540

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1997952549

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1997952549

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1997952549

Country of ref document: EP